Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04533464 · ClinicalTrials.gov registry record · Phase 2
MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome
A Phase 2 study of Trauma and Adult Stem Cells, sponsored by Healios K.K..
- Recruiting
- Registry status
- Phase 2
- Development phase
- 156
- Enrollment target
- 1
- Study location
NCT04533464: Recruiting Phase 2 study of Trauma and Adult Stem Cells, sponsored by Healios K.K..
NCT04533464 is a Phase 2 study of Trauma and Adult Stem Cells that is actively recruiting participants, run by Healios K.K.. The registered enrollment target is 156 participants, below the 305-participant average among 56 other Trauma trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04533464, a Phase 2 study of Trauma and Adult Stem Cells, is actively recruiting participants, sponsored by Healios K.K..
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 156 participants
- Enrollment target
- 1
- Study location
Study Summary
Single center, prospective, randomized, double-blind, pragmatic Phase 2 clinical study in severely injured trauma patients within hours of hospitalization who have survived initial resuscitation.
Conditions Studied
Interventions
- BIOLOGICAL Placebo
- BIOLOGICAL MultiStem
Study Locations (1)
Texas
- Healios Investigational Site - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2020-11-09 |
| Est. Completion | 2025-12 |
| Phase | Phase 2 |
What NCT04533464 shows while recruiting
NCT04533464 is an interventional study that assigns participants to a tested intervention. The registered 156 participants enrollment target is mid-sized for trials with a published cap, below the 305-participant average among 56 other Trauma trials with a reported enrollment target (49% lower).
The record links to 2 conditions, with Trauma appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04533464 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04533464 about?
NCT04533464 is a clinical study titled "MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome". Single center, prospective, randomized, double-blind, pragmatic Phase 2 clinical study in severely injured trauma patients within hours of hospitalization who have survived initial resuscitation.
What is the current status of trial NCT04533464?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 156 participants. The study started on 2020-11-09. Estimated completion is 2025-12.
What conditions does trial NCT04533464 study?
This clinical trial studies the following conditions: Trauma, Adult Stem Cells.
What interventions are being tested in trial NCT04533464?
The interventions under investigation include: Placebo (BIOLOGICAL), MultiStem (BIOLOGICAL).
Who is sponsoring clinical trial NCT04533464?
This trial is sponsored by Healios K.K., which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04533464 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Trauma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04533464's enrollment target sits among peer trials
156 25th of 56 higher than 31 of 56 other Trauma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Trauma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
RECRUITING · Phase 2
-
A Clinical Trial of Interventions to Support Family Surrogates of Critically Ill Patients
RECRUITING · Phase 2
-
Humacyte Human Acellular Vessel (HAV) in Patients With Vascular Trauma
ACTIVE NOT RECRUITING · Phase 2
-
Testing FIRST in Youth Outpatient Psychotherapy
RECRUITING · NA
-
PRESERVE & CONNECT: Impact Study of the BPC
RECRUITING · NA
-
Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03082755 · 156 participants · Phase 4
Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease
- NCT04047628 · 156 participants · Phase 3
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- NCT05173714 · 156 participants · Phase 2
Sit Less, Interact and Move More (SLIMM) 2 Study
- NCT05416307 · 156 participants · Phase 2
Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI